Kunz C, Rudloff S, Baier W, Klein N, Strobel S
Institut für Ernährung, Universität Giessen, 35392 Giessen, Germany.
Annu Rev Nutr. 2000;20:699-722. doi: 10.1146/annurev.nutr.20.1.699.
Research on human milk oligosaccharides (HMOs) has received much attention in recent years. However, it started about a century ago with the observation that oligosaccharides might be growth factors for a so-called bifidus flora in breast-fed infants and extends to the recent finding of cell adhesion molecules in human milk. The latter are involved in inflammatory events recognizing carbohydrate sequences that also can be found in human milk. The similarities between epithelial cell surface carbohydrates and oligosaccharides in human milk strengthen the idea that specific interactions of those oligosaccharides with pathogenic microorganisms do occur preventing the attachment of microbes to epithelial cells. HMOs may act as soluble receptors for different pathogens, thus increasing the resistance of breast-fed infants. However, we need to know more about the metabolism of oligosaccharides in the gastrointestinal tract. How far are oligosaccharides degraded by intestinal enzymes and does oligosaccharide processing (e.g. degradation, synthesis, and elongation of core structures) occur in intestinal epithelial cells? Further research on HMOs is certainly needed to increase our knowledge of infant nutrition as it is affected by complex oligosaccharides.
近年来,对人乳寡糖(HMOs)的研究备受关注。然而,它始于大约一个世纪前,当时观察到寡糖可能是母乳喂养婴儿中所谓双歧杆菌菌群的生长因子,并一直延伸到最近在人乳中发现细胞粘附分子。后者参与识别在人乳中也能找到的碳水化合物序列的炎症事件。上皮细胞表面碳水化合物与人乳中寡糖之间的相似性强化了这样一种观点,即这些寡糖与致病微生物确实会发生特异性相互作用,从而防止微生物附着在上皮细胞上。HMOs可能作为不同病原体的可溶性受体,从而增强母乳喂养婴儿的抵抗力。然而,我们需要更多地了解寡糖在胃肠道中的代谢情况。寡糖被肠道酶降解的程度如何,以及寡糖加工(例如核心结构的降解、合成和延长)是否在肠道上皮细胞中发生?为了增加我们对受复杂寡糖影响的婴儿营养的了解,对HMOs进行进一步研究当然是必要的。